human bladder cancer cell lines sw780 (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC human bladder cancer cell lines sw780
Human Bladder Cancer Cell Lines Sw780, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 339 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bladder+cancer+cell+lines+sw780/SW+780/pm41840064-186-0-26
Average 96 stars, based on 339 article reviews

human bladder cancer cell lines sw780 - by Bioz Stars, 2026-09

96/100 stars

Images

Cell Culture:

Article Title: Methods of using SCD1 antagonists
Article Snippet: .. Materials and Methods for Examples Cell Culture, siRNA Transfection and Reagents The human bladder cancer cell lines SW780, BFTC-905 and Ca129 were obtained from ATCC. .. RT112 cells were purchased from German Collection of Microorganisms and Cell Cultures (DSMZ, Germany).

Article Title: FGFR3 Stimulates Stearoyl CoA Desaturase 1 Activity to Promote Bladder Tumor Growth
Article Snippet: .. Cell culture, siRNA transfection, and reagents The human bladder cancer cell lines SW780, BFTC-905, and Cal29 were obtained from American Type Culture Collection. .. RT112 cells were purchased from German Collection of Microorganisms and Cell Cultures (DSMZ).

Article Title: Long Noncoding RNA Cancer Susceptibility Candidate 8 Suppresses the Proliferation of Bladder Cancer Cells via Regulating Glycolysis.
Article Snippet: Increasing evidence highlights the critical regulatory role of long noncoding RNAs (lncRNAs) in carcinogenesis.. Bladder cancer has become the most prevalent urologic malignancy, which is commonly diagnosed among adults.. In this study, we showed that the lncRNA cancer susceptibility candidate 8 (CASC8) is significantly downregulated in bladder cancers and associated with the advanced stage of bladder cancer patients.

Transfection:

Modification:

Article Title: Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery.
Article Snippet: .. Cell lines and cell cultivation Gemcitabine-sensitive human bladder cancer cell lines SW780 (CRL-2169) and 5637 (HTB-9) (both from ATCC, Manassas, VA, USA) were cultivated in McCoy’s 5a Medium Modified (30-2007, ATCC) and RPMI-1640 Medium (30-2001, ATCC), respectively. .. Gemcitabine less-sensitive human bladder cancer cell line UMUC3 (CRL-1749, ATCC) was cultured in Eagle’s Minimum Essential Medium (30-2003, ATCC).

Article Title: Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery
Article Snippet: .. Gemcitabine-sensitive human bladder cancer cell lines SW780 (CRL-2169) and 5637 (HTB-9) (both from ATCC, Manassas, VA, USA) were cultivated in McCoy’s 5a Medium Modified (30-2007, ATCC) and RPMI-1640 Medium (30-2001, ATCC), respectively. .. Gemcitabine less-sensitive human bladder cancer cell line UMUC3 (CRL-1749, ATCC) was cultured in Eagle’s Minimum Essential Medium (30-2003, ATCC).

Mutagenesis:

Article Title: APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti–PD-1 efficacy in bladder cancer
Article Snippet: .. Human bladder cancer cell lines SW780 (TP53 wild type), EJ (TP53 missense mutant) and UMUC3 (TP53 missense mutant), as well as HEK293T cells, were obtained from ATCC. .. The human bladder cancer cell line T24 (TP53 missense mutant) was purchased from Saibai Kang Bio (Shanghai, China).

Article Title: APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1 efficacy in bladder cancer.
Article Snippet: .. Human bladder cancer cell lines SW780 (TP53 wild type), EJ (TP53 missense mutant) and UMUC3 (TP53 missense mutant), as well as HEK293T cells, were obtained from ATCC. .. The human bladder cancer cell line T24 (TP53 missense mutant) was purchased from Saibai Kang Bio (Shanghai, China).

Review